Characterizing gut microbial structural variation reveals strain heterogeneity and metabolic dysfunction in colorectal cancer

Previous studies investigating gastrointestinal (GI) diseases have primarily focused on the composition, gene expression, and specific strains of gut microbiota. However, the impact of genetic variations, especially structural variations (SVs) in microbial genomes, on the development of GI tumors has been largely overlooked. In this study, we analyzed 1,027 fecal metagenomes from seven data sets and identified 8,278 coverage-defined SVs across 51 bacterial species in the gut microbiomes. We found that SVs were prevalent in the gut microbiota of studied cohorts. Surprisingly, the genetic makeup of SV-based clusters differed significantly between healthy individuals and those with colorectal cancer (CRC), indicating substantial intra-specific diversity within these populations. By integrating taxonomic-SV markers, we achieved optimal accuracy in early CRC detection, and the SVs also displayed regional heterogeneity. Microbial genetic variation provides additional insights into taxonomy and functionality, allowing us to have a more precise understanding of the microbiota associated with CRC. Notably, our study uncovered potential links between microbial SVs and metabolic disorders of CRC, including SV regions that encode glycoside hydrolases associated with disordered carbohydrate metabolism in CRC. We integrated a framework called MicroSVsProfiler to identify and classify SVs in individuals diagnosed with CRC, as well as in healthy controls. Our findings underscore the importance of considering SVs in microbiome studies, especially in the absence of strain-specific differences in abundance. Future research should explore the deeper layer of the microbiota's structural variantome for a better understanding of the occurrence and characteristics of CRC across different stages.IMPORTANCEMost microbiome studies of colorectal cancer focus on which bacterial species are more or less abundant, potentially overlooking genetic differences among strains of the same species. By analyzing 1,027 fecal metagenomes from seven independent cohorts, we show that large-scale changes in bacterial genomes, known as structural variations, provide disease-related information that is not captured by species abundance alone. These strain-level SV signatures distinguished healthy individuals from patients with colorectal cancer, improved early-cancer classification when combined with taxonomic markers, and varied across geographic populations. We also found that cancer-associated structural variations were linked to altered microbial metabolic functions, particularly carbohydrate metabolism and glycoside hydrolases. Together, these findings establish microbial structural variation as a complementary dimension of the gut microbiome and provide a framework for developing more precise, population-aware biomarkers and for investigating how strain-level genetic changes may contribute to metabolic disturbances associated with colorectal cancer.

Authors

Institutions

Publication Details

Journal
mSystems
Published
2026-11-13
DOI
https://doi.org/10.1128/msystems.01109-26
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Characterizing gut microbial structural variation reveals strain heterogeneity and metabolic dysfunction in colorectal cancer

Tao Ding, Ying Cui, Qintian Qiu, Yongqiu Chen
3 links
mSystems
Gut microbiota and health
article

Characterizing gut microbial structural variation reveals strain heterogeneity and metabolic dysfunction in colorectal cancer

Tao Ding, Ying Cui, Qintian Qiu, Yongqiu Chen
article en

Abstract

Previous studies investigating gastrointestinal (GI) diseases have primarily focused on the composition, gene expression, and specific strains of gut microbiota. However, the impact of genetic variations, especially structural variations (SVs) in microbial genomes, on the development of GI tumors has been largely overlooked. In this study, we analyzed 1,027 fecal metagenomes from seven data sets and identified 8,278 coverage-defined SVs across 51 bacterial species in the gut microbiomes. We found that SVs were prevalent in the gut microbiota of studied cohorts. Surprisingly, the genetic makeup of SV-based clusters differed significantly between healthy individuals and those with colorectal cancer (CRC), indicating substantial intra-specific diversity within these populations. By integrating taxonomic-SV markers, we achieved optimal accuracy in early CRC detection, and the SVs also displayed regional heterogeneity. Microbial genetic variation provides additional insights into taxonomy and functionality, allowing us to have a more precise understanding of the microbiota associated with CRC. Notably, our study uncovered potential links between microbial SVs and metabolic disorders of CRC, including SV regions that encode glycoside hydrolases associated with disordered carbohydrate metabolism in CRC. We integrated a framework called MicroSVsProfiler to identify and classify SVs in individuals diagnosed with CRC, as well as in healthy controls. Our findings underscore the importance of considering SVs in microbiome studies, especially in the absence of strain-specific differences in abundance. Future research should explore the deeper layer of the microbiota's structural variantome for a better understanding of the occurrence and characteristics of CRC across different stages.IMPORTANCEMost microbiome studies of colorectal cancer focus on which bacterial species are more or less abundant, potentially overlooking genetic differences among strains of the same species. By analyzing 1,027 fecal metagenomes from seven independent cohorts, we show that large-scale changes in bacterial genomes, known as structural variations, provide disease-related information that is not captured by species abundance alone. These strain-level SV signatures distinguished healthy individuals from patients with colorectal cancer, improved early-cancer classification when combined with taxonomic markers, and varied across geographic populations. We also found that cancer-associated structural variations were linked to altered microbial metabolic functions, particularly carbohydrate metabolism and glycoside hydrolases. Together, these findings establish microbial structural variation as a complementary dimension of the gut microbiome and provide a framework for developing more precise, population-aware biomarkers and for investigating how strain-level genetic changes may contribute to metabolic disturbances associated with colorectal cancer.

mSystems
Sun Yat-sen University (CN)
National Science and Technology Major Project, National Key Research and Development Program of China
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon